积极免疫:一种用于治疗阿尔茨海默病的新疗法策略
1College of Pharmacy, Phase III, Integral University, Lucknow, 226026, India.
European journal of pharmacology
|October 25, 2025
概括
阿尔茨海默病的治疗方法,如免疫疗法,通过向粉样蛋白-β和蛋白来显示有前途. 虽然疫苗正在开发中,但尚未批准用于临床使用.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病是一种进展性神经退行性疾病,导致认知能力下降.
- 目前FDA批准的药物可以治疗阿尔茨海默病的症状,但不能治愈阿尔茨海默病.
- 单克隆抗体 (被动免疫疗法) 向β-粉样蛋白,但产生不一致的结果,质疑粉样蛋白级联假说.
研究的目的:
- 审查阿尔茨海默病的假设,当前的治疗方法及其局限性.
- 探索活性免疫疗法剂,机制和结果.
- 讨论阿尔茨海默病疫苗开发的挑战和未来方向.
主要方法:
- 对有关阿尔茨海默病假设和治疗的现有文献的审查.
- 对活性免疫疗法剂的临床前和临床数据的分析.
- 对阿尔茨海默病疫苗的安全性和有效性数据的评估.
主要成果:
- 活性免疫疗法通过产生针对粉样β和tau的抗体来证明其潜力.
- 候选疫苗CAD106没有出现脑膜炎或中枢神经系统炎症等不良事件.
- 尽管有前临床和早期临床结果很有希望,但目前还没有有效的免疫疗法疫苗获得许可.
结论:
- 活性免疫疗法代表了阿尔茨海默病的有前途的治疗策略.
- 需要进一步的研究和临床试验来克服开发挑战,并将疫苗推向市场.
- 开发有效的阿尔茨海默病疫苗仍然是神经退行性疾病研究的关键目标.
相关概念视频
01:22Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:51Vaccinations
51.2K
Overview
51.2K
01:31Active versus Passive Immunity
10.0K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
10.0K
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
01:29Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936